H. Lepidi, F. Gouriet, D. Raoult Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

P.-Y. Lévy Clinical Microbiology and Infection

M. Benoit, Y. Bechah, C. Capo, P.J. Murray, J.L. Mege, B. Desnues

R. Cavallo Clinical Microbiology and Infection

L. Boyanova Clinical Microbiology and Infection

Efficiency of a phase 1 vaccine for the reduction of vaginal Coxiella burnetii shedding in a clinically affected goat herd E. Rousset, B. Durand, J.L.

Immunosuppressive monoclonal antibodies: current and next generation

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Virological tools to diagnose and monitor hepatitis C virus infection

R. Cantón Clinical Microbiology and Infection

Comparison of the new InoDiag automated fluorescence multiplexed antigen microarray to the reference technique in the serodiagnosis of atypical bacterial.

P. Balraj, G. Vestris, D. Raoult, P. Renesto

W. Li, L. Liu, X. Jiang, X. Guo, M. Garnier, D. Raoult, P. Parola

Link between intracellular pathogens and cardiovascular diseases

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

S. Richard, P. Seng, P. Parola, D. Raoult, B. Davoust, P. Brouqui

B. Desnues, G. Imbert, D. Raoult, J.-L. Mege, E. Ghigo

Vector control: a cornerstone in the malaria elimination campaign

Training for the infectious diseases speciality in Norway

Isospora belli Clinical Microbiology and Infection

Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels B. Sarov, L. Novack, N.

P. Seng, J.M. Rolain, D. Raoult, P. Brouqui

Does it make sense to detect Streptococcus pyogenes during tonsillitis in Europe to prevent acute rheumatic fever? S. Edouard, A. Michel-Lepage, D. Raoult

F. Bittar, J.-M. Rolain Clinical Microbiology and Infection

CMI editorial report 2011 Clinical Microbiology and Infection

Structural studies of lipid A from a lipopolysaccharide of the Coxiella burnetii isolate RSA 514 (Crazy) P. Vadovic, A. Fuleova, R. Ihnatko, L. Skultety,

Levofloxacin in the treatment of ventilator-associated pneumonia

W. Saisongkorh, L. Barrassi, B. Davoust, C. -A. de Broucker, D

Metagenomics and probiotics

Hepatitis B and C virus-related carcinogenesis

A case of pleurisy associated with antibodies to Rickettsia conorii

Rickettsia felis and Rickettsia massiliae in Ivory Coast, Africa

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.

H. Leblebicioglu, C. Eroglu Clinical Microbiology and Infection

Immunohistochemical detection of Coxiella burnetii in an aortic graft

Statin use and clinical outcomes among pneumonia patients

Isolation of Coxiella burnetii from the blood of a patient with positive Anaplasma phagocytophilum serological results A.S. Santos, R. de Sousa, F. Alves,

Clinical Microbiology and Infection

Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Multiplexed whole bacterial antigen microarray, a new format for the automation of serodiagnosis: the culture-negative endocarditis paradigm F. Gouriet,

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Abstracts Clinical Microbiology and Infection

B. La Scola, D. Raoult Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Update on invasive aspergillosis: clinical and diagnostic aspects

S. Shpynov, N. Rudakov, Y. Tohkov, A. Matushchenko, I. Tarasevich, D

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

A monoclonal antibody specific for a unique biomarker, virenose, in a lipopolysaccharide of Coxiella burnetii K. Palkovicova, R. Ihnatko, P. Vadovic,

Three years experience of real-time PCR for the diagnosis of Q fever

Impact of antibiotic restrictions: the patient's perspective

Genotyping Rickettsia conorii detected in patients with Mediterranean spotted fever in Algeria using multispacer typing (MST) L.I. Wenjun, N. Mouffok,

C. Socolovschi, D. Raoult, P. Parola

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Immunohistochemical detection of Coxiella burnetii in chronic Q fever hepatitis H. Lepidi, F. Gouriet, D. Raoult Clinical Microbiology and Infection Volume 15, Pages 169-170 (December 2009) DOI: 10.1111/j.1469-0691.2008.02212.x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 Immunohistochemical detection of Coxiella burnetii in the liver of a patient with chronic Q fever. Bacteria are seen with an intracellular location in macrophages associated with granulomas in the liver parenchyma (monoclonal mouse antibody used at 1 : 2000 dilution, haematoxylin counterstain, original magnification x400). Clinical Microbiology and Infection 2009 15, 169-170DOI: (10.1111/j.1469-0691.2008.02212.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions